Search

Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo

메타 데이터

바이오화학분류
    • 바이오정밀화학
      1. 용매
      2. 화학제품
    • 화장품용 기능성소재
      1. 보습재
      2. 기능성
논문

Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo

학술지

Nucleic acids research

저자명

Sarli, Samantha L; Fakih, Hassan H; Kelly, Karen; Devi, Gitali; Rembetsy-Brown, Julia M; McEachern, Holly R; Ferguson, Chantal M; Echeverria, Dimas; Lee, Jonathan; Sousa, Jacquelyn; Sleiman, Hanadi F; Khvorova, Anastasia; Watts, Jonathan K

초록

<P><B>Abstract</B><P>Glioblastoma multiforme is a universally lethal brain tumor that largely resists current surgical and drug interventions. Despite important advancements in understanding GBM biology, the invasiveness and heterogeneity of these tumors has made it challenging to develop effective therapies. Therapeutic oligonucleotides-antisense oligonucleotides and small-interfering RNAs-are chemically modified nucleic acids that can silence gene expression in the brain. However, activity of these oligonucleotides in brain tumors remains inadequately characterized. In this study, we developed a quantitative method to differentiate oligonucleotide-induced gene silencing in orthotopic GBM xenografts from gene silencing in normal brain tissue, and used this method to test the differential silencing activity of a chemically diverse panel of oligonucleotides. We show that oligonucleotides chemically optimized for pharmacological activity in normal brain tissue do not show consistent activity in GBM xenografts. We then survey multiple advanced oligonucleotide chemistries for their activity in GBM xenografts. Attaching lipid conjugates to oligonucleotides improves silencing in GBM cells across several different lipid classes. Highly hydrophobic lipid conjugates cholesterol and docosanoic acid enhance silencing but at the cost of higher neurotoxicity. Moderately hydrophobic, unsaturated fatty acid and amphiphilic lipid conjugates still improve activity without compromising safety. These oligonucleotide conjugates show promise for treating glioblastoma.</P></P>

발행연도

2024

발행기관

Oxford University Press

ISSN

0305-1048

ISSN

1362-4962

52

9

페이지

pp.4799-4817

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2024-05-22

Export

About

Search

Trend